Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults.
Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults.
复制标题
DOI：
10.1016/j.jsat.2021.108277
复制
发表时间：
2021-09
影响因子：
3.9
通讯作者：
Wainberg M
中科院分区：
文献类型：
--
作者：
Elkington KS;Nunes E;Schachar A;Ryan ME;Garcia A;Van DeVelde K;Reilly D;O'Grady M;Williams AR;Tross S;Wilson P;Cohall R;Cohall A;Wainberg M
为了应对纽约州 (NYS) 的阿片类药物危机，统一法院系统开发了一种新的治疗法庭模式 - 阿片类药物干预法庭 - 设计了大约 10 个基本实践要素，通过更广泛的纳入标准、快速筛查以及与治疗阿片类药物使用障碍 (MOUD) 的药物联系来解决现有毒品法庭在处理阿片类药物成瘾者方面的缺陷。新的法庭模式目前正在全州范围内推广，但鉴于阿片类药物法庭的创新，在拥有各种资源的不同县实施的确切障碍在很大程度上尚不清楚。我们描述了一项新的实施干预措施（阿片类药物法庭 REACH；法庭健康循证方法研究）的开发和功效测试的研究方案，该方案将允许阿片类药物法庭按照 10 个基本要素的框架，在纽约州 10 个县扩大。使用集群随机阶梯楔形 2 型混合有效性实施设计，我们将测试：(a) 阿片类药物法庭 REACH 在改善阿片类药物级联护理（筛查、转诊、治疗登记、MOUD 启动）实施结果方面的实施影响，以及 (b) 阿片类药物法庭 REACH 在改善公共卫生（治疗保留/法庭毕业）和公共安全（累犯）结果方面的临床和成本效益。如果本研究发现阿片类药物法庭 REACH 有效，那么它有可能通过在美国广泛扩大阿片类药物法庭模式来改善法庭系统中对阿片类药物成瘾者的管理。
In response to the opioid crisis in New York State (NYS), the Unified Court System developed a new treatment court model—the opioid intervention court—designed around 10 Essential Elements of practice to address the flaws of existing drug courts in handling those with opioid addiction via broader inclusion criteria, rapid screening, and linkage to medications to treat opioid use disorder (MOUD). The new court model is now being rolled out statewide yet, given the innovation of the opioid court, the exact barriers to implementation in different counties with a range of resources are largely unknown. We describe a study protocol for the development and efficacy-test of a new implementation intervention (Opioid Court REACH; Research on Evidence-Based Approaches to Court Health) that will allow the opioid court, as framed by the 10 Essential Elements, to be scaled-up across 10 counties in NYS. Using a cluster-randomized stepped-wedge type-2 hybrid effectiveness-implementation design, we will test: (a) the implementation impact of Opioid Court REACH in improving implementation outcomes along the opioid cascade of care (screening, referral, treatment enrollment, MOUD initiation), and (b) the clinical and cost effectiveness of Opioid Court REACH in improving public health (treatment retention/court graduation) and public safety (recidivism) outcomes. Opioid Court REACH has the potential to improve management of individuals with opioid addiction in the court system via widespread scale-up of the opioid court model across the U.S., should this study find it to be effective.
登录
查看更多内容
影响因子：
3.5
作者：
Friedmann PD;Hoskinson R;Gordon M;Schwartz R;Kinlock T;Knight K;Flynn PM;Welsh WN;Stein LA;Sacks S;O'Connell DJ;Knudsen HK;Shafer MS;Hall E;Frisman LK;Mat Working Group Of CJ-Dats
通讯作者：
Mat Working Group Of CJ-Dats
影响因子：
5.5
作者：
Luke, Douglas A.;Calhoun, Annaliese;Moreland-Russell, Sarah
通讯作者：
Moreland-Russell, Sarah
影响因子：
2.7
作者：
Andraka-Christou, Barbara;Atkins, Danielle
通讯作者：
Atkins, Danielle
影响因子：
4.2
作者：
Lehman, Wayne E. K.;Fletcher, Bennett W.;Melnick, Gerald
通讯作者：
Melnick, Gerald
影响因子：
4
作者：
De Allegri, Manuela;Pokhrel, Subhash;Becher, Heiko;Dong, Hengjin;Mansmann, Ulrich;Kouyate, Bocar;Kynast-Wolf, Gisela;Gbangou, Adjima;Sanon, Mamadou;Bridges, John;Sauerborn, Rainer
通讯作者：
Sauerborn, Rainer